Biotronik’s Acticor and Rivacor CRM devices bag FDA approval
Biotronik has bagged US FDA approval for its high-voltage cardiac rhythm management (CRM) devices – Acticor and Rivacor range of devices for treating heart arrhythmia or cardiac arrhythmias. The six new tachycardia solutions approved by the FDA are Rivacor VR-T, Rivacor DR-T, Rivacor HF-T QP, Acticor DX, Acticor CRT-DX and Acticor CRT-DX Bipolar. Biotronik is […]